Back

Progressive electrical and structural remodelling in mitral valve prolapse: implications for arrhythmic risk stratification

12 April 2026 (16:30 - 17:15)
Organised by: Logo
Congress Presentation Part of: Congenital heart disease and paediatric cardiology Clinical EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speakers

Photo
Mrs Shiri Margalit

Tel Aviv (Israel)

Photo
Professor Avi Sabbag

Chaim Sheba Medical Center, Ramat Gan (Israel)

5 More presentations in this session

Presentation thumbnail
Impact of electrode size on unipolar and omnipolar voltage mapping in pediatric and adult atria: does size matter?
Assistant Professor M. Van Schie (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Unmasking hidden risk: echocardiographic and electrocardiographic markers of arrhythmic risk in pediatric mitral valve prolapse
Doctor M. Magdy Sharl (Alexandria, EG)
Abstract Slides Video
Presentation thumbnail
Rapid, integrated cardiac screening with a wireless multimodal patch: concurrent valvular, electrophysiologic, and hemodynamic assessment
Ms J. Treffts (Bochum, DE)
Abstract Slides Video
Presentation thumbnail
Effect of pacing/sensing lead addition vs. add-on ICD lead implantation for lead failure on the tricuspid valve function
Doctor B. Kuru Gorgulu (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Risk of adverse events in patients requiring pacemaker implantation after transcatheter aortic valve replacement: observations from a global federated network
Doctor E. Tartaglia (Modena, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Congenital heart disease and paediatric cardiology

The Event

Event poster

EHRA 2026

12 April 2026 16:30 CET
You may be interested in
thumbnail
Congress Presentation
Predictors of and outcomes in arrhythmic mitral valve prolapse
thumbnail
Congress Presentation
Mitral valve prolapse: arrhythmic risk and prognosis
thumbnail
Congress Presentation
Characteristics of patients with mitral valve prolapse presenting with sudden cardiac arrest: a single-center case-control study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources